SMAC產(chǎn)品信息
英文名稱:Diablo homolog, mitochondrial
中文名稱:DIABLO蛋白
靶點(diǎn)別稱:SMAC
物種:Human
標(biāo)簽:His Tag
屬性:Protein
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human SMAC, His Tag (DIO-H5129) is expressed from E. coli cells. It contains AA Ala 56 - Asp 239 (Accession # NP_063940).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 21.7 kDa. The protein migrates as 22 kDa under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 20 mM HEPES, 150 mM NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
Diablo同源物線粒體(Diablo)也被稱為低pI的直接IAP結(jié)合蛋白和第二線粒體衍生的胱天蛋白酶激活劑(SMAC),可以與BIRC2/c-IAP1、BIRC3/c-IAP2、XIAP/BIRC4、BIRC6/bruce和BIRC7/livin相互作用。通過(guò)對(duì)抗凋亡蛋白抑制劑(IAP)的抑制活性,DIABLO還可以通過(guò)激活細(xì)胞色素c/Apaf-1/caspase-9通路中的胱天蛋白酶來(lái)促進(jìn)凋亡。此外,DIABLO通過(guò)抑制BIRC6/bruce與胱天蛋白酶的結(jié)合來(lái)抑制其活性。此外,DIABLO在下調(diào)XIAP/BIRC4豐度的能力方面存在缺陷。
關(guān)鍵字: SMAC;SMAC蛋白;DIABLO重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。